series-a
Stage
About
Crossbridge Bio is a biotech company developing non-opioid pain relief therapies using monoclonal antibodies targeting the Nav1.7 sodium channel.
Explore Crossbridge Bio's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.